|

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

RECRUITINGN/ASponsored by University of California, Irvine
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Irvine
Started2026-09-16
Est. completion2028-08
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
Locations57 sites

Summary

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adults who are eligible for screening based on current U.S. Preventive Services Task Force (USPSTF) guidelines. This pilot randomized controlled trial will enroll approximately 80 participants from UC Irvine Health and Emory Healthcare. Participants will be randomly assigned to receive either enhanced usual care or the Empower LCS/Call+ intervention. The intervention includes educational materials, reminders for patients and primary care providers, and information about financial and community resources when appropriate. Participants who do not complete lung cancer screening after the initial intervention may receive additional telephone-based navigation through the Call+ program to help identify and address barriers to screening and help with scheduling. Participants will complete a baseline survey and follow-up surveys at 4 and 8 months, and researchers will review electronic health record information to determine whether lung cancer screening was discussed, ordered, and completed. Some participants will also be invited to complete a one-time interview about their experiences with the study. The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ intervention and will inform future efforts to improve equitable access to lung cancer screening.

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Must meet current USPSTF eligibility criteria for lung cancer screening (Current criteria: age 50-80 years old with a 20 pack-year smoking history, who currently smoke or have quit within the last 15 years)
2. Must have an electronic health record-assigned primary care provider within University of California Irvine Health or Emory Healthcare
3. Must have recent engagement with respective health system (i.e., office or emergency department (ED) visit, hospitalization with discharged home in the last 12 months, or a scheduled office visit in the next 3 months).
4. Must speak English or Spanish
5. Able and willing to provide informed consent

Exclusion Criteria:

1. Meet the eligibility upper age limit during initial 4-month participation.
2. Have a prior history of lung cancer.
3. Have a new diagnosis of other cancers in the 12 months
4. Have a chest CT or LDCT in the last 12 months
5. Have ICD-10 code of Alzheimer's disease in EHR

Conditions6

CancerEarly Detection of CancerLung CancerLung Cancer ScreeningLung NeoplasmsSmoking, Cigarette

Locations57 sites

UCI Health Family Health Center - Anaheim
Anaheim, California, 92801
Gelareh Sadigh, MD(714) 456-3610empowerlcs@hs.uci.edu
UCI Health - Costa Mesa
Costa Mesa, California, 92627
Gelareh Sadigh, MD(714) 456-3610empowerlsc@hs.uci.edu
CHAO Family Comprehensive Cancer Center- Irvine
Irvine, California, 92612
Gelareh Sadigh, MD(714) 456-3610empowerlcs@hs.uci.edu
UCI Health Gottschalk Medical Plaza
Irvine, California, 92697
Gelareh Sadigh, MD(714) 456-3610empowerlcs@hs.uci.edu
UCI Health - Laguna Hills
Laguna Hills, California, 92653
Gelareh Sadigh, MD(714) 456-3610empowerlcs@hs.uci.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.